Class I and class II histone deacetylases are potential therapeutic targets for treating pancreatic cancer. [electronic resource]
Producer: 20130905Description: e52095 p. digitalISSN:- 1932-6203
- Antineoplastic Agents -- pharmacology
- Apoptosis -- drug effects
- Cell Cycle Checkpoints -- drug effects
- Cell Death -- drug effects
- Cell Division -- drug effects
- Cell Line, Tumor
- Cyclin-Dependent Kinase Inhibitor p21 -- metabolism
- DNA Breaks, Double-Stranded
- Epithelial Cells -- drug effects
- G2 Phase -- drug effects
- Histone Deacetylase Inhibitors -- pharmacology
- Histone Deacetylases -- metabolism
- Histones -- metabolism
- Humans
- Molecular Targeted Therapy
- Pancreatic Neoplasms -- drug therapy
- Tubulin -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.